Evidence map›Paper›PMID 42779985›Full record

ArticlebioRxiv : the preprint server for biology2026

Akshara Sakunthala Velmurugan, Kiriaki Paschoudi, Jack A Queenan, Sucheol Gil, Aidan Maynard, Charlie E Fontana, Reva Sharma, Anika Long, Chang Li, Hongjie Wang and 11 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Akshara Sakunthala VelmuruganUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Kiriaki PaschoudiGene and Cell Therapy Center, Hematology Department, George Papanicolaou Hospital, Thessaloniki, Greece.ORCID 0009-0000-2378-1442
Jack A QueenanMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-1057-3892
Sucheol GilUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Aidan MaynardUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Charlie E FontanaUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Reva SharmaUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.ORCID 0009-0002-4381-0989
Anika LongUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.ORCID 0009-0005-1364-1266
Chang LiUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Hongjie WangUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Anna K AndersonUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.ORCID 0000-0003-1331-2102
Aphrodite GeorgakopoulouUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
Nikoletta PsathaDepartment of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki.ORCID 0000-0002-3139-057X
Maria GiannakiSecond Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki.
Efthymia VlachakiSecond Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki.ORCID 0000-0002-2043-9630
Nouraiz AhmedMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Alexander A SousaMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
David R LiuMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Evangelia YannakiUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.ORCID 0000-0002-9849-1279
André LieberUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.ORCID 0000-0001-6742-6266
Karthik V KaruppusamyUniversity of Washington, Department of Medicine, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.ORCID 0009-0004-9136-3049

Funding

In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell DiseaseR01HL130040 · NHLBI · UNIVERSITY OF WASHINGTON · PI LIEBER, ANDRE MICHAEL · 2016 to 2024
$4.3M
Bill & Melinda Gates Foundation INV-017692NHLBI NIH HHS R01 HL130040
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42779985
PMCPMC13596342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.